{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:33:56Z","timestamp":1773509636378,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100014738","name":"VGST","doi-asserted-by":"crossref","award":["VGST(VGST\/P-2\/CISEE\/GRD-231\/2013-14)"],"award-info":[{"award-number":["VGST(VGST\/P-2\/CISEE\/GRD-231\/2013-14)"]}],"id":[{"id":"10.13039\/501100014738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014738","name":"VGST","doi-asserted-by":"crossref","award":["[Project sanction order: No.VGST\/CISEE\/282\/2012-13]"],"award-info":[{"award-number":["[Project sanction order: No.VGST\/CISEE\/282\/2012-13]"]}],"id":[{"id":"10.13039\/501100014738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001843","name":"SERB","doi-asserted-by":"crossref","award":["SERB [EMR\/2017\/00088\/dated 3\/01\/2019]"],"award-info":[{"award-number":["SERB [EMR\/2017\/00088\/dated 3\/01\/2019]"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s43440-021-00266-8","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T21:03:40Z","timestamp":1619471020000},"page":"1328-1343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Targeting HIF-1\u03b1 by newly synthesized Indolephenoxyacetamide (IPA) analogs to induce anti-angiogenesis-mediated solid tumor suppression"],"prefix":"10.1007","volume":"73","author":[{"given":"Fares Hezam","family":"Al-Ostoot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankith","family":"Sherapura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vigneshwaran","family":"V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giridhara","family":"Basappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"H.K.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhakar","family":"B.T","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-6419","authenticated-orcid":false,"given":"Shaukath Ara","family":"Khanum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"266_CR1","doi-asserted-by":"publisher","first-page":"549412","DOI":"10.1155\/2015\/549412","volume":"2015","author":"A Zimna","year":"2015","unstructured":"Zimna A, Kurpisz M. Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. BioMed Res Int. 2015;2015:549412.","journal-title":"BioMed Res Int"},{"key":"266_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","volume":"76","author":"GL Semenza","year":"2014","unstructured":"Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 2014;76:39\u201365.","journal-title":"Annu Rev Physiol"},{"key":"266_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.09.011","author":"Z Ma","year":"2020","unstructured":"Ma Z, Xiang X, Li S, Xie P, Gong Q, Goh BC, et al. Targeting hypoxia-inducible factor-1, for cancer treatment: recent advances in developing small-molecule inhibitors from natural compounds. Semin Cancer Biol. 2020. https:\/\/doi.org\/10.1016\/j.semcancer.2020.09.011.","journal-title":"Semin Cancer Biol."},{"key":"266_CR4","doi-asserted-by":"publisher","first-page":"115207","DOI":"10.1016\/j.bmc.2019.115207","volume":"28","author":"S Fuse","year":"2020","unstructured":"Fuse S, Suzuki K, Kuchimaru T, Kadonosono T, Ueda H, Sato S, et al. Design, synthesis, and evaluation of indeno [2, 1-c] pyrazolones for use as inhibitors against hypoxia-inducible factor (HIF)-1 transcriptional activity. Bioorganic Med Chem. 2020;28:115207.","journal-title":"Bioorganic Med Chem"},{"key":"266_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-1086-5","volume":"20","author":"X Jin","year":"2020","unstructured":"Jin X, Dai L, Ma Y, Wang J, Liu Z. Implications of HIF-1 in the tumorigenesis and progression of pancreatic cancer. Cancer Cell Int. 2020;20:1\u201311.","journal-title":"Cancer Cell Int"},{"key":"266_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.biopha.2014.07.004","volume":"68","author":"HD Gurupadaswamy","year":"2014","unstructured":"Gurupadaswamy HD, Thirusangu P, Avin BV, Vigneshwaran V, Kumar MP, Abhishek TS, et al. DAO-9 (2, 5-di (4-aryloylaryloxymethyl)-1, 3, 4-oxadiazole) exhibits p53 induced apoptogenesis through caspase-3 mediated endonuclease activity in murine carcinoma. Biomed Pharmacother. 2014;68:791\u20137.","journal-title":"Biomed Pharmacother"},{"key":"266_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ccr.2008.04.012","volume":"253","author":"Y Shimazaki","year":"2009","unstructured":"Shimazaki Y, Yajima T, Takani M, Yamauchi O. Metal complexes involving indole rings: structures and effects of metal\u2013indole interactions. Coord Chem Rev. 2009;253:479\u201392.","journal-title":"Coord Chem Rev"},{"key":"266_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bioorg.2019.02.007","volume":"85","author":"M Demurtas","year":"2019","unstructured":"Demurtas M, Baldisserotto A, Lampronti I, Moi D, Balboni G, Pacifico S, et al. Indole derivatives as multifunctional drugs: synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indolehydrazones. Bioorganic Chem. 2019;85:568\u201376.","journal-title":"Bioorganic Chem"},{"key":"266_CR9","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1016\/j.bmcl.2010.07.039","volume":"20","author":"NV Lakshmi","year":"2010","unstructured":"Lakshmi NV, Thirumurugan P, Noorulla KM, Perumal PT. InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives. Bioorganic Med Chem Lett. 2010;20:5054\u201361.","journal-title":"Bioorganic Med Chem Lett"},{"key":"266_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0014-827X(99)00035-X","volume":"54","author":"I Merino","year":"1999","unstructured":"Merino I, Monge A, Font M, de Irujo JJ, Alberdi E, Santiago E, et al. Synthesis and anti-HIV-1 activities of new pyrimido [5, 4-b] indoles. IlFarmaco. 1999;54:255\u201364.","journal-title":"IlFarmaco"},{"key":"266_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ijc.21445","volume":"118","author":"CT Brew","year":"2006","unstructured":"Brew CT, Aronchik I, Hsu JC, Sheen JH, Dickson RB, Bjeldanes LF, et al. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells. Int J Cancer. 2006;118:857\u201368.","journal-title":"Int J Cancer"},{"key":"266_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s001090000088","volume":"78","author":"Q Meng","year":"2000","unstructured":"Meng Q, Qi M, Chen DZ, Yuan R, Goldberg ID, Rosen E, et al. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin\/catenin complexes. J Mol Med. 2000;78:155\u201365.","journal-title":"J Mol Med"},{"key":"266_CR13","doi-asserted-by":"publisher","first-page":"127244","DOI":"10.1016\/j.molstruc.2019.127244","volume":"1202","author":"FH Al-Ostoot","year":"2020","unstructured":"Al-Ostoot FH, Geetha DV, Mohammed YH, Akhileshwari P, Sridhar MA, Khanum SA. Design-based synthesis, molecular docking analysis of an anti-inflammatory drug, and geometrical optimization and interaction energy studies of an indole acetamide derivative. J Mol Struct. 2020;1202:127244.","journal-title":"J Mol Struct"},{"key":"266_CR14","doi-asserted-by":"publisher","first-page":"127743","DOI":"10.1016\/j.bmcl.2020.127743","volume":"33","author":"FH Al-Ostoot","year":"2021","unstructured":"Al-Ostoot FH, Grisha S, Mohammed YH, Vivek HK, Khanum SA. Molecular docking and synthesis of caffeic acid analogous and its anti-inflammatory, analgesic and ulcerogenic studies. Bioorganic Med Chem Lett. 2021;33:127743.","journal-title":"Bioorganic Med Chem Lett"},{"key":"266_CR15","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1002\/slct.201900646","volume":"4","author":"HA Khamees","year":"2019","unstructured":"Khamees HA, Mohammed YH, Swamynayaka A, Al-Ostoot FH, Sert Y, Alghamdi S, et al. Molecular structure, DFT, vibrational spectra with fluorescence effect, hirshfeld surface, docking simulation and antioxidant activity of thiazole derivative. ChemistrySelect. 2019;4:4544\u201358.","journal-title":"ChemistrySelect"},{"key":"266_CR16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.lfs.2013.10.001","volume":"93","author":"VL Ranganatha","year":"2013","unstructured":"Ranganatha VL, Avin BV, Thirusangu P, Prashanth T, Prabhakar BT, Khanum SA. Synthesis, angiopreventive activity, and in vivo tumor inhibition of novel benzophenone\u2013benzimidazole analogs. Life Sci. 2013;93:904\u201311.","journal-title":"Life Sci"},{"key":"266_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejmech.2014.01.050","volume":"75","author":"BR Vijay Avin","year":"2014","unstructured":"Vijay Avin BR, Thirusangu P, Ranganatha VL, Firdouse A, Prabhakar BT, Khanum SA. Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis. Eur J Med Chem. 2014;75:211\u201321.","journal-title":"Eur J Med Chem"},{"key":"266_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10456-016-9528-3","volume":"20","author":"P Thirusangu","year":"2017","unstructured":"Thirusangu P, Vigneshwaran V, Prashanth T, Avin BV, Malojirao VH, Rakesh H, et al. BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53\/MDM2-mediated HIF-1? proteasomal degradation. Angiogenesis. 2017;20:55\u201371.","journal-title":"Angiogenesis"},{"key":"266_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cei.12959","volume":"189","author":"V Vigneshwaran","year":"2017","unstructured":"Vigneshwaran V, Thirusangu P, Vijay Avin BR, Krishna V, Pramod SN, Prabhakar BT. Immunomodulatory glc\/man-directed Dolichos lablab lectin (DLL) evokes anti-tumour response in vivo by counteracting angiogenic gene expressions. Clin Exp Immunol. 2017;189:21\u201335.","journal-title":"Clin Exp Immunol"},{"key":"266_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbrc.2014.04.090","volume":"448","author":"BV Avin","year":"2014","unstructured":"Avin BV, Prabhu T, Ramesh CK, Vigneshwaran V, Riaz M, Jayashree K, et al. New role of lupeol in reticence of angiogenesis, the cellular parameter of neoplastic progression in tumorigenesis models through altered gene expression. Biochem Biophys Res Commun. 2014;448:139\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"266_CR21","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s00044-019-02357-x","volume":"28","author":"Z Zabiulla","year":"2019","unstructured":"Zabiulla Z, Malojirao VH, Mohammed YH, Thirusangu P, Prabhakar BT, Khanum SA. Synthesis, molecular docking, and apoptogenic efficacy of novel N-heterocycle analogs to target B-cell lymphoma 2\/X-linked inhibitors of apoptosis proteins to regress melanoma. Med Chem Res. 2019;28:1132\u201360.","journal-title":"Med Chem Res"},{"key":"266_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.intimp.2016.07.024","volume":"39","author":"V Vigneshwaran","year":"2016","unstructured":"Vigneshwaran V, Thirusangu P, Madhusudana S, Krishna V, Pramod SN, Prabhakar BT. The latex sap of the \u2018Old World Plant\u2019Lagenaria siceraria with potent lectin activity mitigates neoplastic malignancy targeting neovasculature and cell death. Int Immunopharmacol. 2016;39:158\u201371.","journal-title":"Int Immunopharmacol"},{"key":"266_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bcp.2016.11.009","volume":"125","author":"P Thirusangu","year":"2017","unstructured":"Thirusangu P, Vigneshwaran V, Ranganatha VL, Avin BV, Khanum SA, Mahmood R, et al. A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1\u03b1 nuclear translocation and its target gene activation against neoplastic progression. Biochem Pharmacol. 2017;125:26\u201340.","journal-title":"Biochem Pharmacol"},{"key":"266_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10637-006-6587-0","volume":"24","author":"BT Prabhakar","year":"2006","unstructured":"Prabhakar BT, Khanum SA, Shashikanth S, Salimath BP. Antiangiogenic effect of 2-benzoyl\u2013phenoxy acetamide in EAT cell is mediated by HIF-1\u03b1 and down regulation of VEGF of in-vivo. Invest New Drugs. 2006;24:471\u20138.","journal-title":"Invest New Drugs"},{"key":"266_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bmc.2005.08.039","volume":"14","author":"BT Prabhakar","year":"2006","unstructured":"Prabhakar BT, Khanum SA, Jayashree K, Salimath BP, Shashikanth S. Anti-tumor and proapoptotic effect of novel synthetic benzophenone analogues in Ehrlich ascites tumor cells. Bioorganic Med Chem. 2006;14:435\u201346.","journal-title":"Bioorganic Med Chem"},{"key":"266_CR26","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3892\/ijo.2016.3709","volume":"49","author":"E Maj","year":"2016","unstructured":"Maj E, Papiernik D, Wietrzyk J. Antiangiogenic cancer treatment: The great discovery and greater complexity. Int J Oncol. 2016;49:1773\u201384.","journal-title":"Int J Oncol"},{"key":"266_CR27","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2174\/1568026620666200622150325","volume":"20","author":"D Xu","year":"2020","unstructured":"Xu D, Xu Z. Indole Alkaloids with potential anticancer activity. Curr Top Med Chem. 2020;20:1938\u201349.","journal-title":"Curr Top Med Chem"},{"key":"266_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.biopha.2017.08.105","volume":"95","author":"YH Mohammed","year":"2017","unstructured":"Mohammed YH, Thirusangu P, Vigneshwaran V, Prabhakar BT, Khanum SA. The anti-invasive role of novel synthesized pyridazine hydrazide appended phenoxy acetic acid against neoplastic development targeting matrix metallo proteases. Biomed Pharmacother. 2017;95:375\u201386.","journal-title":"Biomed Pharmacother"},{"key":"266_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc2868","volume":"10","author":"AS Chung","year":"2010","unstructured":"Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer. 2010;10:505\u201314.","journal-title":"Nat Rev Cancer"},{"key":"266_CR30","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/nprot.2007.368","volume":"2","author":"MS Rogers","year":"2007","unstructured":"Rogers MS, Birsner AE, D\u2019amato RJ. The mouse cornea micropocket angiogenesis assay. Nat Protoc. 2007;2:2545\u201350.","journal-title":"Nat Protoc."},{"key":"266_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00432-008-0497-9","volume":"135","author":"S Shivakumar","year":"2009","unstructured":"Shivakumar S, Prabhakar BT, Jayashree K, Rajan MG, Salimath BP. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast. J Cancer Res Clin Oncol. 2009;135:627\u201336.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-021-00266-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T10:40:00Z","timestamp":1632480000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-021-00266-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1007\/s43440-021-00266-8","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}